MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Free Cash flow
-$28,271K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Borrowings under credit facility
Depreciation, amortization, and ...
Inventory reserve expenses
Others
Negative Cash Flow Breakdown
Net loss
Capital expenditures
Inventories
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Net loss
-20,908
-2,222
-22,795
-67,175
Depreciation, amortization, and impairment
13,493
13,078
12,941
51,302
Inventory reserve expenses
2,900
3,049
2,383
25,393
Amortization of operating lease assets, debt costs, and other assets
1,058
1,975
1,582
2,377
Provision for expected credit losses
719
-211
629
1,837
Deferred income taxes
93
-110
321
12
Share-based compensation expense
6,533
7,214
7,181
14,293
Loss on disposal of fixed assets
-331
-279
-280
-581
Change in valuation of investment securities
16
7
10
31
Change in fair value of contingent consideration
750
660
-427
-1,373
Other
178
-711
-2,315
1,188
Accounts receivable
2,964
4,714
1,958
-5,089
Inventories
8,845
1,279
3,579
5,890
Prepaid expenses and other current assets
1,459
4,723
-1,191
394
Accounts payable
-4,368
8,255
3,482
-9,138
Other current liabilities
-5,221
6,784
12,711
-21,763
Contingent consideration milestone payment
-
0
1,340
-
Other long-term assets and liabilities
-472
1,042
2,505
684
Net cash used in operating activities
-17,610
27,697
12,402
-6,752
Capital expenditures
10,661
10,877
9,904
13,845
Other investing activities
-146
-6
-10
-12
Net cash used in investing activities
-10,515
-10,871
-9,894
-13,833
Proceeds from issuance of common shares
-
2,839
36
3,054
Payments related to withholdings for share-based compensation
-
264
9
159
Contingent consideration milestone payment
-
0
4,990
-
Payments related to finance lease obligation
31
198
189
375
Borrowings under credit facility
64,025
-
-
-
Payment of debt issuance costs and other financing activities
24
0
0
531
Net cash provided by (used in) financing activities
63,970
2,377
-5,152
1,989
Effect of exchange rate changes on cash
-90
-34
-99
1,547
Net change in cash and cash equivalents
35,755
19,169
-2,743
-17,049
Cash, cash equivalents, and restricted cash at the beginning of period
85,115
65,946
85,738
-
Cash, cash equivalents, and restricted cash at the end of period
120,870
85,115
65,946
-
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Borrowings under credit
facility
$64,025K
Net cash provided by
(used in) financing...
$63,970K
Canceled cashflow
$55K
Net change in cash
and cash...
$35,755K
Canceled cashflow
$28,215K
Payments related to
finance lease...
$31K
Payment of debt issuance
costs and other...
$24K
Depreciation, amortization,
and impairment
$13,493K
Share-based compensation
expense
$6,533K
Inventory reserve
expenses
$2,900K
Amortization of operating
lease assets, debt...
$1,058K
Change in fair value of
contingent consideration
$750K
Provision for expected
credit losses
$719K
Other long-term
assets and liabilities
-$472K
Loss on disposal of
fixed assets
-$331K
Deferred income taxes
$93K
Other investing
activities
-$146K
Net cash used in
operating activities
-$17,610K
Net cash used in
investing activities
-$10,515K
Effect of exchange rate
changes on cash
-$90K
Canceled cashflow
$26,349K
Canceled cashflow
$146K
Net loss
-$20,908K
Capital expenditures
$10,661K
Inventories
$8,845K
Other current
liabilities
-$5,221K
Accounts payable
-$4,368K
Accounts receivable
$2,964K
Prepaid expenses and
other current assets
$1,459K
Other
$178K
Change in valuation of
investment securities
$16K
Buy us a coffee
Orthofix Medical Inc. (OFIX)
Orthofix Medical Inc. (OFIX)